Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard C Crist

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Cell Cycle (Georgetown, Tex.)|March 10, 2011
Identification of Mom12 and Mom13, two novel modifier loci of Apc (Min) -mediated intestinal tumorigenesisRichard C Crist, Jacquelyn J Roth, Michael P Lisanti, et al.
The American Journal of Drug and Alcohol Abuse|January 16, 2018
Pharmacogenetic analysis of opioid dependence treatment dose and dropout rateRichard C Crist, James Li, Glenn A Doyle, et al.
Addiction Biology|March 1, 2022
Post-treatment effects of topiramate on alcohol-related outcomes: A combined analysis of two placebo-controlled trialsHenry R Kranzler, Richard Feinn, Timothy Pond, et al.
The American Journal of Drug and Alcohol Abuse|October 29, 2025
Racial and ethnic disparities in buprenorphine retention and treatment outcome in a longitudinal cohort of U.S. veterans with opioid use disorderRachel Vickers-Smith, Richard C Crist, Rachel L Kember, et al.
Addiction (Abingdon, England)|January 6, 2023
An intensive longitudinal examination of topiramate treatment for alcohol use disorder: a secondary analysis of data from a randomized controlled trialVictoria R Votaw, Katie Witkiewitz, M Lee Van Horn, et al.
Drug and Alcohol Dependence|May 28, 2021
Combined analysis of the moderating effect of a GRIK1 polymorphism on the effects of topiramate for treating alcohol use disorderHenry R Kranzler, Emily E Hartwell, Richard Feinn, et al.
The American Journal of Drug and Alcohol Abuse|August 19, 2021
Differential expression and transcription factor binding associated with genotype at a pharmacogenetic variant in <i>OPRD1</i>Richard C Crist, Gabriella Arauco-Shapiro, Alexander Zhang, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|October 2, 2010
The armadillo repeat domain of Apc suppresses intestinal tumorigenesisRichard C Crist, Jacquelyn J Roth, Amy A Baran, et al.
Genes & Genomics|July 31, 2024
Analysis of single-cell transcriptome data from a mouse model implicates protein synthesis dysfunction in schizophreniaAndrew E Weller, Thomas N Ferraro, Glenn A Doyle, et al.
Molecular Metabolism|December 23, 2021
Single nuclei RNA sequencing of the rat AP and NTS following GDF15 treatmentBenjamin C Reiner, Richard C Crist, Tito Borner, et al.
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Cell Cycle (Georgetown, Tex.)|March 10, 2011
Identification of Mom12 and Mom13, two novel modifier loci of Apc (Min) -mediated intestinal tumorigenesisRichard C Crist, Jacquelyn J Roth, Michael P Lisanti, et al.
The American Journal of Drug and Alcohol Abuse|January 16, 2018
Pharmacogenetic analysis of opioid dependence treatment dose and dropout rateRichard C Crist, James Li, Glenn A Doyle, et al.
Addiction Biology|March 1, 2022
Post-treatment effects of topiramate on alcohol-related outcomes: A combined analysis of two placebo-controlled trialsHenry R Kranzler, Richard Feinn, Timothy Pond, et al.
The American Journal of Drug and Alcohol Abuse|October 29, 2025
Racial and ethnic disparities in buprenorphine retention and treatment outcome in a longitudinal cohort of U.S. veterans with opioid use disorderRachel Vickers-Smith, Richard C Crist, Rachel L Kember, et al.
Addiction (Abingdon, England)|January 6, 2023
An intensive longitudinal examination of topiramate treatment for alcohol use disorder: a secondary analysis of data from a randomized controlled trialVictoria R Votaw, Katie Witkiewitz, M Lee Van Horn, et al.
Drug and Alcohol Dependence|May 28, 2021
Combined analysis of the moderating effect of a GRIK1 polymorphism on the effects of topiramate for treating alcohol use disorderHenry R Kranzler, Emily E Hartwell, Richard Feinn, et al.
The American Journal of Drug and Alcohol Abuse|August 19, 2021
Differential expression and transcription factor binding associated with genotype at a pharmacogenetic variant in <i>OPRD1</i>Richard C Crist, Gabriella Arauco-Shapiro, Alexander Zhang, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|October 2, 2010
The armadillo repeat domain of Apc suppresses intestinal tumorigenesisRichard C Crist, Jacquelyn J Roth, Amy A Baran, et al.
Genes & Genomics|July 31, 2024
Analysis of single-cell transcriptome data from a mouse model implicates protein synthesis dysfunction in schizophreniaAndrew E Weller, Thomas N Ferraro, Glenn A Doyle, et al.
Molecular Metabolism|December 23, 2021
Single nuclei RNA sequencing of the rat AP and NTS following GDF15 treatmentBenjamin C Reiner, Richard C Crist, Tito Borner, et al.
Pageof 8